Kim YJ - Search Results

1

Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.

Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH. Son MJ, et al. Among authors: kim h, kim yj, kim js, kim jt, kim mh, kim jh. Int J Oncol. 2006 Jan;28(1):53-9. Int J Oncol. 2006. PMID: 16327979

2

Osmolarity hypersensitivity of hog1 deleted mutants is suppressed by mutation in KSS1 in budding yeast Saccharomyces cerevisiae.

Lee SJ, Park SY, Na JG, Kim YJ. Lee SJ, et al. Among authors: kim yj. FEMS Microbiol Lett. 2002 Mar 19;209(1):9-14. doi: 10.1111/j.1574-6968.2002.tb11102.x. FEMS Microbiol Lett. 2002. PMID: 12007647

3

Anti-angiogenic and anti-tumor invasive activities of tissue inhibitor of metalloproteinase-3 from shark, Scyliorhinus torazame.

Kang JA, Kim JT, Song HS, Bae MK, Yi EY, Kim KW, Kim YJ. Kang JA, et al. Among authors: kim yj, kim jt, kim kw. Biochim Biophys Acta. 2003 Mar 17;1620(1-3):59-64. doi: 10.1016/s0304-4165(02)00508-1. Biochim Biophys Acta. 2003. PMID: 12595074

4

SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.

Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ, Kim KW. Lee SW, et al. Among authors: kim yj, kim wj, kim kw. Nat Med. 2003 Jul;9(7):900-6. doi: 10.1038/nm889. Nat Med. 2003. PMID: 12808449

5

Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.

Yi EY, Jeong EJ, Song HS, Lee MS, Kang DW, Joo JH, Kwon HS, Lee SH, Park SK, Chung SG, Cho EH, Kim YJ. Yi EY, et al. Among authors: kim yj. Int J Oncol. 2004 Aug;25(2):365-72. Int J Oncol. 2004. PMID: 15254733

6

Hypoxia-responsive element-mediated soluble Tie2 vector exhibits an anti-angiogenic activity in vitro under hypoxic condition.

Jeong CH, Lee YM, Choi KS, Seong YR, Kim YJ, Im DS, Kim KW. Jeong CH, et al. Among authors: kim yj, kim kw. Int J Oncol. 2005 Jan;26(1):211-6. Int J Oncol. 2005. PMID: 15586242

7

Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function.

Lee SH, Son MJ, Oh SH, Rho SB, Park K, Kim YJ, Park MS, Lee JH. Lee SH, et al. Among authors: kim yj. Cancer Res. 2005 Jan 1;65(1):137-48. Cancer Res. 2005. PMID: 15665289

8

Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1alpha degradation.

Kim WJ, Cho H, Lee SW, Kim YJ, Kim KW. Kim WJ, et al. Among authors: kim yj, kim kw. Int J Oncol. 2005 Apr;26(4):1049-52. Int J Oncol. 2005. PMID: 15754001

9

Anti-angiogenic and anti-tumor apoptotic activities of a topoisomerase II inhibiting agent SJ-8026.

Yi EY, Jeong EJ, Kang DW, Joo JH, Kwon HS, Lee SH, Park SK, Chung SG, Cho EH, Kim YJ. Yi EY, et al. Among authors: kim yj. Int J Oncol. 2005 Jun;26(6):1613-20. Int J Oncol. 2005. PMID: 15870877

10

Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.

Son MJ, Song HS, Kim MH, Kim JT, Kang CM, Jeon JW, Park SY, Kim YJ, Groves MD, Park K, Kim JH, Nam DH. Son MJ, et al. Among authors: kim yj, kim jt, kim mh, kim jh. Int J Oncol. 2006 Jun;28(6):1385-92. Int J Oncol. 2006. PMID: 16685440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,062 results

Search Page

Filters